Standout Papers

In vitro and in vivo characterization of the JAK1 selectivity of upadacitinib (ABT-494) 2018 2026 2020 2023 261
  1. In vitro and in vivo characterization of the JAK1 selectivity of upadacitinib (ABT-494) (2018)
    Julie Parmentier, J W Voss et al. BMC Rheumatology

Immediate Impact

2 from Science/Nature 62 standout
Sub-graph 1 of 21

Citing Papers

Covalent targeted radioligands potentiate radionuclide therapy
2024 StandoutNature
SwissDock 2024: major enhancements for small-molecule docking with Attracting Cavities and AutoDock Vina
2024 Standout
2 intermediate papers

Works of Jonathan S. George being referenced

Tricyclic Covalent Inhibitors Selectively Target Jak3 through an Active Site Thiol
2015

Author Peers

Author Last Decade Papers Cites
Jonathan S. George 153 113 85 139 7 452
Elizabeth Kieras 152 53 23 108 13 417
Stacey Shepard 76 97 109 68 6 380
Béatrice Vayssière 190 47 40 154 5 384
Danielle G. Aspar 142 101 115 129 8 456
Clarissa J. Watts 41 115 25 115 7 378
E. P. Reddy 214 197 32 44 11 474
Carole Ferraro 79 158 6 112 5 496
Rosemary Zhang 98 108 98 40 10 375
Sarah Pope 150 197 34 75 5 492
Misti Linaberry 118 44 13 89 5 377

All Works

Loading papers...

Rankless by CCL
2026